The migrating motor complex: control mechanisms and its role in health and disease

被引:241
作者
Deloose, Eveline [1 ]
Janssen, Pieter [2 ]
Depoortere, Inge [1 ]
Tack, Jan [1 ]
机构
[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, B-3000 Louvain, Belgium
[2] Shire, B-2300 Turnhout, Belgium
关键词
MOTILIN RECEPTOR AGONIST; INTERDIGESTIVE GASTROINTESTINAL MOTILITY; SMALL-INTESTINAL MOTILITY; CONCENTRATION-DEPENDENT STIMULATION; GROWTH-HORMONE RELEASE; PLASMA GHRELIN LEVELS; III-LIKE CONTRACTIONS; PANCREATIC-POLYPEPTIDE; FOOD-INTAKE; PHASE-III;
D O I
10.1038/nrgastro.2012.57
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The migrating motor complex (MMC) is a cyclic, recurring motility pattern that occurs in the stomach and small bowel during fasting; it is interrupted by feeding. The MMC is present in the gastrointestinal tract of many species, including humans. The complex can be subdivided into four phases, of which phase III is the most active, with a burst of contractions originating from the antrum or duodenum and migrating distally. Control of the MMC is complex. Phase III of the MMC with an antral origin can be induced in humans through intravenous administration of motilin, erythromycin or ghrelin, whereas administration of serotonin or somatostatin induces phase III activity with duodenal origin. The role of the vagus nerve in control of the MMC seems to be restricted to the stomach, as vagotomy abolishes the motor activity in the stomach, but leaves the periodic activity in the small bowel intact. The physiological role of the MMC is incompletely understood, but its absence has been associated with gastroparesis, intestinal pseudo-obstruction and small intestinal bacterial overgrowth. Measuring the motility of the gastrointestinal tract can be important for the diagnosis of gastrointestinal disorders. In this Review we summarize current knowledge of the MMC, especially its role in health and disease.
引用
收藏
页码:271 / 285
页数:15
相关论文
共 205 条
[1]   NERVOUS CONTROL OF MIGRATORY MYOELECTRIC COMPLEX OF THE SMALL BOWEL [J].
AEBERHARD, PF ;
MAGNENAT, LD ;
ZIMMERMANN, WA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 238 (02) :G102-G108
[2]  
Aerssens J., 2004, Neurogastroenterol. Motil, V16, P841
[3]   Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects [J].
Akamizu, T ;
Takaya, K ;
Irako, T ;
Hosoda, H ;
Teramukai, S ;
Matsuyama, A ;
Tada, H ;
Miura, K ;
Shimizu, A ;
Fukushima, M ;
Yokode, M ;
Tanaka, K ;
Kangawa, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (04) :447-455
[4]   Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite [J].
Akamizu, Takashi ;
Iwakura, Hiroshi ;
Ariyasu, Hiroyuki ;
Hosoda, Hiroshi ;
Murayama, Toshinori ;
Yokode, Masayuki ;
Teramukai, Satoshi ;
Seno, Hiroshi ;
Chiba, Tsutomu ;
Noma, Shunichi ;
Nakai, Yoshikatsu ;
Fukunaga, Mikhiko ;
Nakai, Yoshihide ;
Kangawa, Kenji .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (04) :491-498
[5]   Xenin - a novel suppressor of food intake in rats [J].
Alexiou, C ;
Zimmermann, JP ;
Schick, RR ;
Schusdziarra, V .
BRAIN RESEARCH, 1998, 800 (02) :294-299
[6]  
Ang DC, 2008, GASTROENTEROLOGY, V134, pA314
[7]  
Aprile Lilian Rose Otoboni, 1995, Arquivos de Gastroenterologia, V32, P71
[8]   Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach [J].
Ariga, H. ;
Tsukamoto, K. ;
Chen, C. ;
Mantyh, C. ;
Pappas, T. N. ;
Takahashi, T. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (08) :675-680
[9]   Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats [J].
Ataka, Koji ;
Inui, Akio ;
Asakawa, Akihiro ;
Kato, Ikuo ;
Fujimiya, Mineko .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (05) :G1210-G1218
[10]   Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels [J].
Barkan, AL ;
Dimaraki, EV ;
Jessup, SK ;
Symons, KV ;
Ermolenko, M ;
Jaffe, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) :2180-2184